Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial-Reference-Cited by-同舟云学术

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial

Published:2019-08 Issue: Volume:288 Page:87-93
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Essebag Vidal,AlTurki Ahmed,Proietti Riccardo,Healey Jeff S.,Wells George A.,Verma Atul,Krahn Andrew D.,Simpson Christopher S.,Ayala-Paredes Felix,Coutu Benoit,Leather Richard,Ahmad Kamran,Toal Satish,Sapp John,Sturmer Marcio,Kavanagh Katherine,Crystal Eugene,Leiria Tiago L.L.,Seifer Colette,Rinne Claus,Birnie David

Funder

Canadian Institutes of Health Research

CIHR

Fonds de recherche du Québec - Santé

Ministry of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia's project;Mond;Pacing Clin. Electrophysiol.,2011

2. Nichols CI, Vose JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J. Am. Heart Assoc. 2017;6(1).